Last reviewed · How we verify

Ethinodiol — Competitive Intelligence Brief

Ethinodiol (etynodiol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Progestin. Area: Other.

marketed Progestin Amine oxidase [flavin-containing] A Other Live · refreshed every 30 min

Target snapshot

Ethinodiol (etynodiol).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ethinodiol TARGET etynodiol marketed Progestin Amine oxidase [flavin-containing] A 1966-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Progestin class)

  1. · 2 drugs in this class
  2. Trieu, Nguyen Thi, M.D. · 2 drugs in this class
  3. Bristol-Myers Squibb · 2 drugs in this class
  4. Baylor Research Institute · 1 drug in this class
  5. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 drug in this class
  6. Exeltis Usa Inc · 1 drug in this class
  7. IBSA Institut Biochimique SA · 1 drug in this class
  8. Hillel Yaffe Medical Center · 1 drug in this class
  9. Fdn Consumer · 1 drug in this class
  10. Bio Meds Pharmaceutica Ltda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ethinodiol — Competitive Intelligence Brief. https://druglandscape.com/ci/etynodiol. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: